Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases.The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
Financials ($)
Sales 2014 -
EBIT 2014 -29,3 M
Net income 2014 -30,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -37,4 M
Net income 2015 -38,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 36,2 M
More Financials
Latest news on ANTA PHAR
4d ago ANTHERA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial ..
5d ago ANTHERA PHARMACEUTICALS : Licenses Japan Rights for Blisibimod to Zenyaku Kogyo ..
12/03 ANTHERA PHARMACEUTICALS : and Patheon Sign Manufacturing Agreement for Liprotama..
11/26 ANTHERA PHARMACEUTICALS : Reports 2014 Third Quarter Financial Results and Opera..
11/23 ANTHERA PHARMACEUTICALS : to Present at Annual Piper Jaffray Healthcare Conferen..
11/21 ANTHERA PHARMACEUTICALS : Notice of Delisting or Failure to Satisfy a Continued ..
11/20 ANTHERA PHARMACEUTICALS : and Patheon Sign Manufacturing Agreement for Liprotama..
11/14 ANTHERA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
More news
Sector news
12h ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
1d ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
1d ago CUBIST PHARMACEUTICALS : FDA OKs Cubist antibiotic for serious infections
More sector news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF